IL6 and plasma cell myeloma: The mechanisms of ATE in myeloma patients are multifactorial and include increased levels of procoagulant factors such as von Willebrand factor and factor VIII and high levels of inflammatory cytokines such as interleukin 6 and tumor necrosis factors [21, 22].